Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
Core EBITDA Growth

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results

DR LAL PATHLABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 27.63-13.3225.7722.3217.38

What is the latest Core EBITDA Growth ratio of DR LAL PATHLABS ?

The latest Core EBITDA Growth ratio of DR LAL PATHLABS is 27.63 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202427.63
Mar2023-13.32
Mar202225.77
Mar202122.32
Mar202017.38

How is Core EBITDA Growth of DR LAL PATHLABS Trending?

Years Core EBITDA Growth % Change
Mar2024 27.63
Positive
Mar2023 -13.32
Negative
Mar2022 25.77
15.46
Mar2021 22.32
28.42
Mar2020 17.38 -

Other Financial Ratios of DR LAL PATHLABS


Compare Core EBITDA Growth ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹24,912.8 Cr -2.5% -3.8% 16.2% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹98,334.3 Cr -1.4% -1.3% 27.1% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹95,006.5 Cr -2.3% 0.9% 63.3% Stock Analytics
FORTIS HEALTHCARE ₹49,098.7 Cr -5.3% 7.7% 76.7% Stock Analytics
GLOBAL HEALTH ₹28,904.0 Cr -3.4% 0.2% 19.9% Stock Analytics
NARAYANA HRUDAYALAYA ₹25,517.5 Cr -1.8% 0.5% 2% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

-2.5%

-3.8%

16.2%

SENSEX

2.5%

-0.5%

19.7%


You may also like the below Video Courses